Letter raises concerns over compliance with FDA rules

12/7/2012 | Pharmalot.com

The FDA slapped Shanghai Huhui Daily Use Chemical Products with a warning letter for several violations, including redacting production records. These moves "raise serious concerns regarding the integrity, reliability and traceability of the data generated and documented in your batch production records," the FDA said in the letter.

View Full Article in:

Pharmalot.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC